PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Aripiprazole
Presentation Product Chemical substance Chapter Items dispensed
Elozar 10mg orodispersible tablets
0402010ADBEAAAE
Elozar Aripiprazole Central Nervous System 1
Abilify 9.75mg/1.3ml solution for injection vials
0402010ADBBAHAH
Abilify Aripiprazole Central Nervous System No data available
Abilify Maintena 720mg/2.4ml prolonged-release inj pfs
0402020ADBBADAD
Abilify Maintena Aripiprazole Central Nervous System No data available
Abilify Maintena 960mg/3.2ml prolonged-release inj pfs
0402020ADBBACAC
Abilify Maintena Aripiprazole Central Nervous System No data available
Aripiprazole 300mg inj vials
0402020ADAAAEAE
Aripiprazole Aripiprazole Central Nervous System No data available
Aripiprazole 7.5mg/ml oral solution
0402010ADAAAJAJ
Aripiprazole Aripiprazole Central Nervous System No data available
Aripiprazole 960mg/3.2ml prolonged-release inj pf syringes
0402020ADAAACAC
Aripiprazole Aripiprazole Central Nervous System No data available
Arpoya 15mg tablets
0402010ADBDACAB
Arpoya Aripiprazole Central Nervous System No data available
Arpoya 30mg tablets
0402010ADBDADAC
Arpoya Aripiprazole Central Nervous System No data available
Elozar 15mg orodispersible tablets
0402010ADBEABAF
Elozar Aripiprazole Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.